- Reply to C. Ren et al. Journal of Clinical Oncology. 2018 Academic Article GET IT
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial.
Times cited: 53